2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 43.348 | 47.573 | 38.087 | 27.675 | 39.867 | 46.613 | 63.262 | 85.656 | 83.512 | 96.179 |
Total Income - EUR | 43.430 | 47.745 | 39.581 | 27.695 | 40.026 | 49.704 | 64.801 | 86.086 | 84.733 | 115.121 |
Total Expenses - EUR | 34.743 | 43.998 | 37.247 | 33.662 | 39.335 | 48.021 | 60.796 | 66.169 | 65.579 | 95.449 |
Gross Profit/Loss - EUR | 8.688 | 3.747 | 2.334 | -5.967 | 691 | 1.683 | 4.005 | 19.917 | 19.154 | 19.671 |
Net Profit/Loss - EUR | 7.387 | 2.320 | 1.953 | -6.244 | 292 | 1.186 | 3.549 | 19.289 | 18.408 | 18.521 |
Employees | 3 | 3 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pauseriu Med-Vet S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 17.465 | 17.878 | 16.381 | 16.104 | 15.808 | 3.008 | 2.951 | 21.389 | 19.863 | 15.508 |
Current Assets | 18.224 | 17.198 | 18.179 | 20.701 | 29.308 | 27.491 | 30.009 | 32.906 | 44.726 | 52.339 |
Inventories | 9.726 | 4.818 | 7.824 | 11.066 | 17.395 | 18.194 | 13.197 | 15.856 | 23.011 | 25.244 |
Receivables | 6.456 | 9.324 | 6.628 | 6.617 | 7.085 | 6.151 | 6.573 | 6.704 | 6.735 | 5.659 |
Cash | 2.041 | 3.056 | 3.727 | 3.017 | 4.828 | 3.146 | 10.239 | 10.347 | 14.980 | 21.436 |
Shareholders Funds | 30.719 | 33.295 | 25.344 | 18.671 | 18.459 | 5.773 | 9.102 | 28.158 | 46.865 | 53.282 |
Social Capital | 48 | 48 | 48 | 47 | 46 | 45 | 44 | 43 | 44 | 43 |
Debts | 4.970 | 1.781 | 9.216 | 18.134 | 26.658 | 24.725 | 23.858 | 24.621 | 16.772 | 13.997 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.516 | 951 | 568 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Pauseriu Med-Vet S.r.l.